🔗 Share this article

An underground economy for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Investigational Treatment Acquiring Popularity Via Social Media

Retatrutide, which is still in research studies, is being promoted by online personalities for its alleged fat-burning properties. Viewers are urged to contact these profiles directly for source information, while also receiving promotional offers.

Active Trade on Messaging Platforms

Additionally, a robust market exists on Telegram, where groups with numerous of members share comparison photos, injection guides and assertions of next-day UK delivery. Sellers market the substance there before redirecting customers to WhatsApp for transactions.

Learning About The Experimental Drug

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and chemists have warned that the sale of what is still an unlicensed drug in the United Kingdom is worrisome and could lead to users administering products of unknown origin.

Several professionals said the demand for retatrutide could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the British medical regulations.

Some content creators attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach pharmaceutical, advertising, and customer laws, potentially leading to penalties, legal action or imprisonment.

Service Response and Content Elimination

Based on TikTok, the service has taken down problematic material and banned related keywords and search suggestions. The company said it was dedicated to maintaining the service secure and allocating resources in enhancing compliance measures.

Digital Trading Activities

Research also found groups with up to 9,000 participants selling the experimental drug using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up channels with numerous of users, populated with images of weight loss, glowing reviews and detailed guides for preparing or administering at home.

Within moments of entering one group, a vendor posted contact information, where most transactions occur. The seller provided an guidebook and promised delivery within 48 hours. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one inquired about body mass, medical conditions or previous experience.

Product Information and Costs

Within these groups, posts show dark colored packages with postal service labels, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with purified liquid, or pre-filled pens typically sold at 160 pounds for 20mg. When questioned how long a injector should be used, vendors give conflicting responses ranging from a several days to “depends on your body”.

Platform Moderation and Security Measures

A representative for Telegram said it actively moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting substances they can’t verify. Even if the research behind this drug is valid, these digital versions may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service connected the surge in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But fake treatments are highly risky. You cannot know what’s inside or whether the environment they were produced in was sterile,” she said.

Her team has previously seen individuals harmed by self-injection from unverified suppliers. “We understand the disappointment, but buying from messaging apps or communication platforms is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.”

Producer Position

A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a Lilly experimental product not yet authorized … may expose users to potentially serious health risks”.